- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07488455
Effectiveness of Video-Based or Written Pelvic Floor Education in Postpartum Women
June 16, 2026 updated by: Ayse Naz Kalem, Ankara Etlik City Hospital
An Evaluation of the Effectiveness of Video-Based or Written Pelvic Floor Education on Knowledge Levels and Pelvic Floor Function in Postpartum Women
The aim of this study is to evaluate the effect of written or visual information provided outside of routine postpartum follow-up on pelvic floor knowledge and pelvic floor function in women during the postpartum period.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
141
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ayse Naz Kalem Ozgen, Specialist
- Phone Number: +90 0312 797 00 00
- Email: kalemnaz@gmail.com
Study Locations
-
-
Yenimahalle
-
Ankara, Yenimahalle, Turkey (Türkiye), 06010
- Recruiting
- Ankara Etlik City Hospital
-
Contact:
- Ayse Naz Kalem Ozgen, Specialist
- Phone Number: +90 0312 797 00 00
- Email: kalemnaz@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Be between the ages of 18 and 45
- Single pregnancy
- Full-term delivery
- Be willing to participate in the study
- Be literate in Turkish
Exclusion Criteria:
- Presence of fecal or urinary incontinence prior to pregnancy
- Presence of neurological or orthopedic problems that could cause pelvic floor dysfunction
- Presence of psychiatric illness or cognitive impairment that makes it difficult to answer questions
- History of pelvic surgery
- History of high-risk pregnancy (preeclampsia, eclampsia, multiple pregnancy, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: video-based education group
Women in the first group will be shown an educational video covering pelvic floor anatomy, pelvic floor dysfunction, risk factors, and pelvic floor exercises via a QR code prior to their postpartum discharge.
|
An educational video covering pelvic floor anatomy, pelvic floor dysfunction, risk factors, and pelvic floor exercises
|
|
Active Comparator: written education group
The women in the second group will be given a written text with the same content as that provided to the women in the first group, and this text will also be explained to them verbally.
|
A written text covering pelvic floor anatomy, pelvic floor dysfunction, risk factors, and pelvic floor exercises
|
|
No Intervention: Conventional group
Women in the third group will undergo routine postnatal follow-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pelvic Floor Health Knowledge Questionnaire
Time Frame: second day of postpartum and 6th week of postpartum
|
second day of postpartum and 6th week of postpartum
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pelvic Floor Questionnaire for Pregnant Women and Postpartum Women
Time Frame: second day of postpartum and 6th week of postpartum
|
second day of postpartum and 6th week of postpartum
|
|
Pelvic Floor Distress Index-20
Time Frame: second day of postpartum and 6th week of postpartum
|
second day of postpartum and 6th week of postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Study Registration Dates
First Submitted
March 18, 2026
First Submitted That Met QC Criteria
March 18, 2026
First Posted (Actual)
March 23, 2026
Study Record Updates
Last Update Posted (Actual)
June 17, 2026
Last Update Submitted That Met QC Criteria
June 16, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- AEŞH-EK-2026-016
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.